Table 1.
Demographic profile and histological diagnosis in 42 patients with lung cancer.
Table 2.
Biodistribution of 18F-FETNIM and 18F-FMISO on PET/CT in Patients with Lung Cancer.
Fig 1.
Major organs and regions uptake at 2 h after injection of 18F-FETNIM (A) in squamous carcinoma patient and 18F-FMISO (B) in small cell lung cancer patient. Arrows point to tumor.
Table 3.
Semiquantitative Assessment of 18F-FETNIM and 18F-FMISO Uptake in Tumor Under Different Conditions.